oppn parties Covaxin To Be Produced By Other Vaccine Manufacturers
OPINIONS : Strongly Expressed

January 29, 2023

People Are Talking About

Welcoming 2023

News Snippets

  • RBI governor Shaktikanta Das says that inflation is easing and the current account deficit is manageable
  • Adani Enterprises FPO sees just 1% subscription on the first day as the stock goes down to Rs 2762, much below the price band of Rs 3112-3276
  • Stocks bleed on Friday post the Hindenburg report as Adani stocks are hammered: Sensex loses 874 points to 59330 and Nifty 287 points to 17604
  • Rs 263cr TDS scam detected by the I-T department. A mid-level officer was the kingpin and had amassed huge wealth
  • Women's U-19 World Cup -India reaches the final by beating New Zealand by 8 wickets
  • New Zealand beat India by 21 runs in the first T20 as spinners choke Indian batters
  • Sania Mirza and Rohan Bopanna lose in the Australian Open finals
  • Sania Mirza and Rohan Bopanna lose in the final of the Australian Open
  • India to play New Zealand in the first T20 of the three-match series in Ranchi today
  • RBI has proposed special purpose vehicles (SPEs) mechanism to sell bad loans to interested investors via securitization
  • JD(U) decides not to attend the Bharat Jodo Yatra finale in Srinagar
  • Hindenburg defends its report on the Adani group, dares Gautam Adani to sue it in the US
  • BJP's talks with Tipra Motha in Tripura make no headway but the party is confident of winning in the ensuing elections
  • Pathan is a super hit at the box office: Rs 57cr in India (worldwide Rs 106cr) on Day 1 and then Rs 70cr on Day 2 which was Republic Day holiday
  • Centre tells Delhi HC that Covid vaccines can't be mixed when taking the second dose
A Mirage2000 and A Sukhoi 30 of the Indian Air Force on a training mission crashed separately, in Bharatpur in Rajasthan and Morena in Madhya Pradesh, killing one pilot
oppn parties
Covaxin To Be Produced By Other Vaccine Manufacturers

By Linus Garg
First publised on 2021-05-14 01:29:06

About the Author

Sunil Garodia Linus tackles things head-on. He takes sides in his analysis and it fits excellently with our editorial policy. No 'maybe's' and 'allegedly' for him, only things in black and white.

Nearly a month after Prime Minister Modi first talked about using the entire vaccine manufacturing capacity in the country to produce the Covid vaccines and former prime minister and Congress leader Dr Manmohan Singh urged the government to invoke compulsory licensing provisions to allow all capable manufacturers to produce the vaccines, the government has invited all vaccine manufacturers in India to produce the indigenously developed (by ICMR and Bharat Biotech) Covaxin that is currently being made only by Bharat Biotech. NITI Aayog member Dr V K Paul said that Bharat Biotech has agreed to this arrangement.

This is a good move as it will help the government procure more doses from additional and captive sources at an attractive price. But it is regrettable that it took the government one month to take this decision. Under normal circumstances, such delays are part and parcel of both governance and corporate negotiations. But when there is a pandemic situation, the Disaster Management Act is in force and vaccines are in short supply threatening to derail the vaccine drive, one thinks decisions need to be taken on war footing. Such delays cannot be condoned in these troubled times.

But there is a stumbling block in the process as not all vaccine manufacturers in India have a BSL3 (Biosafety Level 3) lab which is necessary to inactivate a live virus in order to produce the Covid vaccines. The government must help those vaccine manufacturers who do not have this facility to get the lab up and running as fast as possible. It must provide them with funds and if import of equipment is required, it must allow and facilitate that. It must also assist them in getting the imported raw materials and provide them advance payments to fund their working capital requirements. Hopefully, once these manufacturers start production in full, there will be no vaccine shortage in India.